PhenixFIN Corporation PFX Q1 2026 Earnings Strong EPS Beat Driven by Investment Portfolio Stock Remains Flat Radian Group Inc RDN Q1 2026 Earnings EPS Beats Estimates by 285 as Stock Declines TVTX Q1 2026 Earnings EPS Miss as PreRevenue Biotech Ramps Up Spending CHCT Q1 2026 Earnings EPS Soars Past Estimates with 449 Surprise BWNB Q1 2026 Earnings Significant EPS Miss Triggers Negative Market Response Allogene Therapeutics Edges Higher Testing Key Resistance at 21 Halozyme Therapeutics HALO Rises Modestly Support and Resistance Levels in Focus VICI Properties Holds Steady Near Key Support as REIT Sector Faces Mixed Signals Camden National Corporation CAC Holds Near Support Amid Modest Decline XGN Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Revenue Uncertainty